Keymed Biosciences Inc.'s (HKG:2162) 6.8% Loss Last Week Hit Both Individual Investors Who Own 37% as Well as Institutions
Keymed Biosciences Inc.'s (HKG:2162) 6.8% Loss Last Week Hit Both Individual Investors Who Own 37% as Well as Institutions
Key Insights
主要见解
- The considerable ownership by retail investors in Keymed Biosciences indicates that they collectively have a greater say in management and business strategy
- A total of 10 investors have a majority stake in the company with 51% ownership
- Institutions own 30% of Keymed Biosciences
- Keymed Biosciences中零售投资者持有的相当大的所有权说明他们在管理和业务策略方面集体拥有更大的发言权。
- 10个投资者拥有该公司51%的股权。
- 机构持有Keymed Biosciences的30%股份。
To get a sense of who is truly in control of Keymed Biosciences Inc. (HKG:2162), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, around 37% to be precise, is retail investors. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
要了解Keymed Biosciences Inc. (HKG:2162)真正的控制者,重要的是了解业务的所有权结构。持有公司最多股票的集团(约37%)是零售投资者,换句话说,该集团将从其对公司的投资中获得最多(或者损失最多)收益。
Following a 6.8% decrease in the stock price last week, retail investors suffered the most losses, but institutions who own 30% stock also took a hit.
上周股价下跌6.8%,零售投资者遭受了最大损失,但持有30%股票的机构也受到了打击。
In the chart below, we zoom in on the different ownership groups of Keymed Biosciences.
下面的图表展示了Keymed Biosciences的不同所有权团体。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240722/0-e49702d3554c95fa39833e810cfc3cda-0-38a731e6850e6313ea4636aa0fa88bb4.png/big)
What Does The Institutional Ownership Tell Us About Keymed Biosciences?
机构所有权告诉我们关于Keymed Biosciences的什么?
Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.
许多机构衡量其业绩的标准是一个近似于当地市场的指数。因此,他们通常更加关注包括在主要指数中的公司。
Keymed Biosciences already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Keymed Biosciences, (below). Of course, keep in mind that there are other factors to consider, too.
Keymed Biosciences已经有机构在股东登记册上了,他们拥有该公司的相当大股份。这表明在专业投资者中有一定的信誉。但我们不能仅仅依靠这个事实,因为机构也会犯错误的投资,就像每个人一样。如果两个大型机构投资者同时试图抛售股票,股价大幅下跌并不罕见。因此,检查Keymed Biosciences的过去收益轨迹(下面)是值得的。当然,也要记住还有其他因素需要考虑。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240722/0-e49702d3554c95fa39833e810cfc3cda-1-603e477619eb7188e1fe55347a1d3181.png/big)
We note that hedge funds don't have a meaningful investment in Keymed Biosciences. Looking at our data, we can see that the largest shareholder is Moonshot Holdings Limited with 28% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 5.0% and 4.9%, of the shares outstanding, respectively.
我们注意到对于Keymed Biosciences而言,对冲基金没有意义的投资。查看我们的数据,我们可以看到最大的股东是持有28%流通股的Moonshot Holdings Limited。同时,第二和第三大的股东持有流通股的5.0%和4.9%。
On further inspection, we found that more than half the company's shares are owned by the top 10 shareholders, suggesting that the interests of the larger shareholders are balanced out to an extent by the smaller ones.
进一步调查发现,该公司的股份超过一半由前十大股东持有,表明较大股东的利益在某种程度上被较小股东平衡。
While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.
虽然仔细研究公司的机构持股数据是有意义的,但研究分析师对该股票的看法也是有意义的。有相当数量的分析师在跟踪该股票,因此了解他们对于未来发展的总体看法可能会有所帮助。
Insider Ownership Of Keymed Biosciences
Keymed Biosciences的内部所有权
The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.
公司内部人员的定义可能是主观的,并且在不同的司法管辖区之间有所不同。我们的数据反映了个人内部人员,至少捕捉到董事会成员的记录。公司管理人员向董事会报告,后者应该代表股东的利益。值得注意的是,有时高级管理人员自己也在董事会中。
Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.
当内部人持股情况表明领导层思考和公司真正所有者一样时,内部所有权是积极的。然而,高达内部人士所有权也可能为公司内的小团体带来巨大的权力。在某些情况下,这可能是负面的。
Our data cannot confirm that board members are holding shares personally. It is unusual not to have at least some personal holdings by board members, so our data might be flawed. A good next step would be to take a look at this free summary of insider buying and selling.
我们无法证实董事会成员是否个人持有股份。董事会成员没有至少持有一些股份是不寻常的,所以我们的数据可能有误。下一步是查看这篇有关股票买入和卖出的免费总结,以进一步了解该问题。
General Public Ownership
一般大众所有权
The general public-- including retail investors -- own 37% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.
普通公众--包括零售投资者--拥有公司的37%股份,因此不容易被忽视。尽管该所有权比例相当大,但如果决策与其他大股东不相符,它可能不足以改变公司政策。
Private Company Ownership
私有公司的所有权
Our data indicates that Private Companies hold 28%, of the company's shares. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.
我们的数据表明,私有公司持有该公司28%的股份。仅从这一事实很难得出任何结论,因此值得研究谁拥有这些私有公司的股份。有时,内部人员或其他相关方通过单独的私人公司在公共公司持有股份。
Next Steps:
下一步:
While it is well worth considering the different groups that own a company, there are other factors that are even more important. Be aware that Keymed Biosciences is showing 2 warning signs in our investment analysis , and 1 of those makes us a bit uncomfortable...
虽然考虑拥有公司的不同集团非常值得,但还有其他更重要的因素。请注意,Keymed Biosciences在我们的投资分析中显示了2个警告信号,其中1个让我们有点不舒服……
But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.
但最终,决定该业务所有者将获得多大利益的是未来而非过去。因此,我们认为最好查看此免费报告,以了解分析师是否预测更光明的未来。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的数据是使用最后一个财务报表日期结束的为期12个月的数据计算的。这可能与全年年度报告数据不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有反馈?对内容感到担忧?请直接与我们联系。或者,发送电子邮件至editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
对本文有反馈?对内容感到担忧?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。